News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Agilent Technologies Inc. (A) Expands Life Science Disease Research Portfolio with Eurofins MWG Operon Asset Purchase



11/16/2009 2:52:50 PM

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today announced it has purchased the MassCode Tag technology from Eurofins MWG Operon, a division of Eurofins. The purchase includes the MassCode trademarks and intellectual property, including four families of patents. Agilent will use MassCode Tag technology to develop new research products for pathogen identification, leveraging its strength in polymerase chain reaction (PCR) and mass spectroscopy. Under the agreement, Eurofins MWG Operon will continue as a supplier of the core component for the new products.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES